A randomized, observer-blind, active-controlled, parallel-group, multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of compound S0597 by intranasal route in healthy subjects

Trial Profile

A randomized, observer-blind, active-controlled, parallel-group, multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of compound S0597 by intranasal route in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs SUN 0597 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 21 Mar 2012 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
    • 12 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top